A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa

P

Power Life Sciences

Status

Begins enrollment in 6 months

Conditions

Hidradenitis Suppurativa

Study type

Observational

Funder types

Industry

Identifiers

NCT06201858
67172350

Details and patient eligibility

About

This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors. Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged ≥ 18 years old
  • Diagnosis of hidradenitis suppurativa
  • Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion criteria

  • Female patients who are currently pregnant or nursing
  • Inability to perform regular electronic reporting
  • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Michael B Gill

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems